CIK 0001824893 · Non-accelerated filer<br>Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 301374889
- Phone
- 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series B Common Warrants | −111,656 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series B Common Warrants | +111,656 | 111,656 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series C Common Warrants | −352,225 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series C Common Warrants | −397,773 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series D Common Warrants | −352,225 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series D Common Warrants | −397,773 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series E Common Warrants | +161,943 | 161,943 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series E Common Warrants | +182,884 | 182,884 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series E Common Warrants | +172,414 | 172,414 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Second Tranche Units (Right to Buy) | +485,830 | 485,830 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Second Tranche Units (Right to Buy) | +548,653 | 548,653 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Second Tranche Units (Right to Buy) | +517,241 | 517,241 | ||
| 2025-03-24 | Williams Charles O CFO and COO | Returned to the company · Series A Common Stock Warrant (right to buy) | −1,474 | 0 | ||
| 2025-03-24 | Williams Charles O CFO and COO | Returned to the company · Series B Common Stock Warrant (right to buy) | −1,603 | 0 | ||
| 2025-03-24 | Williams Charles O CFO and COO | Returned to the company · Series C Common Stock Warrant (right to buy) | −5,712 | 0 | ||
| 2025-03-24 | Williams Charles O CFO and COO | Returned to the company · Series D Common Stock Warrant (right to buy) | −5,712 | 0 | ||
| 2025-03-24 | Williams Charles O CFO and COO | Grant or award · Series A Common Stock Warrant (right to buy) | +1,474 | 1,474 | ||
| 2025-03-24 | Williams Charles O CFO and COO | Grant or award · Series B Common Stock Warrant (right to buy) | +1,603 | 1,603 | ||
| 2025-03-24 | Parker Craig C Chief Executive Officer | Returned to the company · Series A Common Stock Warrant (right to buy) | −1,474 | 0 | ||
| 2025-03-24 | Parker Craig C Chief Executive Officer | Returned to the company · Series B Common Stock Warrant (right to buy) | −1,603 | 0 |
Page 8 of 12 · 237 trades